No Data
What does AI pharmaceuticals still lack before a market explosion? | Focus
① From the discovery of targets to the identification of preclinical candidate compounds, current generative AI mainly focuses on the early stages of drug development, which can lead to significant acceleration; ② If AI in drug development is to further expand the realm of possibilities, it must explore more profitable real-world applications.
Sanai Health Industry Group Company Limited (HKG:1889) Not Doing Enough For Some Investors As Its Shares Slump 25%
SANAI HEALTH GP (01889): Chan Wan-fong has been appointed as the company secretary.
SANAI HEALTH GP (01889) announced that Li Wanshan has resigned as (i) company secretary; (ii) Hong Kong joint exchange...
SANAI HEALTH GP (01889.HK) has appointed Xu Wan dan as an independent non-executive Director.
Gelonghui, December 10th, SANAI HEALTH GP (01889.HK) announced that Ms. Xu Wandan has been appointed as an independent non-executive director. The Board of Directors announced that Mr. Zhang Ruigen has resigned as an independent non-executive director, effective December 10, 2024, to devote more time to his personal affairs.
Earnings Troubles May Signal Larger Issues for Sanai Health Industry Group (HKG:1889) Shareholders
SANAI HEALTH GP: Interim Report 2024
Benign Growth For Sanai Health Industry Group Company Limited (HKG:1889) Underpins Stock's 28% Plummet
